Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oncogene mutations as intermediate markers

D Sidransky1, J Boyle, W Koch

  • 1Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, MD 21203-6402.

Journal of Cellular Biochemistry. Supplement
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The National Audit of Metastatic Breast Cancer (NAoMe): Sharing Key Findings and Recommendations From the 2025 State of the Nation Report.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Hospital Factors Influencing the Mobility of Patients for Systemic Therapies in Breast and Bowel Cancer in the Metastatic Setting: A National Population-based Evaluation.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Progress in High-Speed Spin Testing of Superconducting Wire and Tapes for High-Field NMR Magnet Qualification.

Journal of physics. Conference series·2022
Same author

Radiant Exitance of Old, New, and Damaged LED Light Curing Units.

Operative dentistry·2022
Same author

Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021
Same author

What is the current practice for managing patients with chronic limb-threatening ischaemia in vascular surgery services? A survey of UK vascular surgeons.

Annals of the Royal College of Surgeons of England·2021

Identifying early genetic markers in tumors is crucial for diagnosing premalignant lesions and enabling chemoprevention. Research focuses on specific point mutations, like p53 mutations in aerodigestive tract cancers, as potential early indicators of malignant transformation.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Tumors develop from genetic alterations, including proto-oncogene activation and tumor suppressor gene inactivation.
  • Advances allow detection of rare mutated cells amidst normal cells.
  • Identifying early genetic markers could provide intermediate endpoints for cancer research and diagnosis.

Purpose of the Study:

  • To explore the potential of identifying early genetic markers for malignant transformation.
  • To establish precise histopathologic and genetic tumor models for marker identification.
  • To investigate candidate markers for premalignant lesions and chemoprevention strategies.

Main Methods:

  • Review of theoretical frameworks for identifying clonal cell populations with early genetic markers.

Related Experiment Videos

  • Emphasis on the need for precise histopathologic and genetic tumor models.
  • Discussion of specific point mutations as ideal early markers.

    • Main Results:

    • Theoretically, identifying clonal populations with early genetic markers can lead to valuable intermediate endpoints.
    • Specific point mutations occurring early in tumorigenesis are ideal candidates.
    • p53 point mutations in squamous cell carcinoma of the aerodigestive tract are proposed as an early candidate marker.

    Conclusions:

    • Early detection of genetic changes is key to diagnosing premalignant lesions.
    • Precise tumor models are essential for identifying reliable genetic markers.
    • Candidate markers like p53 mutations offer potential for early cancer diagnosis and chemoprevention.